12,835
Views
215
CrossRef citations to date
0
Altmetric
Review Article

Insights into direct nose to brain delivery: current status and future perspective

, , , , &
Pages 75-86 | Received 29 Apr 2013, Accepted 23 Aug 2013, Published online: 09 Oct 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (25)

Raj Kumar, Keshaw Ram Aadil, Kunal Mondal, Yogendra Kumar Mishra, David Oupicky, Seeram Ramakrishna & Ajeet Kaushik. (2022) Neurodegenerative disorders management: state-of-art and prospects of nano-biotechnology. Critical Reviews in Biotechnology 42:8, pages 1180-1212.
Read now
Prabakaran A, Mukta Agrawal, Mithun Rajendra Dethe, Hafiz Ahmed, Awesh Yadav, Umesh Gupta & Amit Alexander. (2022) Nose-to-brain drug delivery for the treatment of Alzheimer’s disease: current advancements and challenges. Expert Opinion on Drug Delivery 19:1, pages 87-102.
Read now
Shourya Tripathi, Ujala Gupta, Rewati Raman Ujjwal & Awesh K. Yadav. (2021) Nano-lipidic formulation and therapeutic strategies for Alzheimer’s disease via intranasal route. Journal of Microencapsulation 38:7-8, pages 572-593.
Read now
Andrea Perrelli, Parisa Fatehbasharzad, Valerio Benedetti, Chiara Ferraris, Marco Fontanella, Elisa De Luca, Mauro Moglianetti, Luigi Battaglia & Saverio Francesco Retta. (2021) Towards precision nanomedicine for cerebrovascular diseases with emphasis on Cerebral Cavernous Malformation (CCM). Expert Opinion on Drug Delivery 18:7, pages 849-876.
Read now
Saima Zameer, Javed Ali, Divya Vohora, Abul Kalam Najmi & Mohd Akhtar. (2021) Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer’s disease in intracerebroventricular streptozotocin model for brain delivery. Journal of Drug Targeting 29:2, pages 199-216.
Read now
Mihika Shringarpure, Sankalp Gharat, Munira Momin & Abdelwahab Omri. (2021) Management of epileptic disorders using nanotechnology-based strategies for nose-to-brain drug delivery. Expert Opinion on Drug Delivery 18:2, pages 169-185.
Read now
Małgorzata Panek, Paweł Kawalec, Andrzej Pilc & Władysław Lasoń. (2020) Developments in the discovery and design of intranasal antidepressants. Expert Opinion on Drug Discovery 15:10, pages 1145-1164.
Read now
Atinderpal Kaur, Kuldeep Nigam, Sukriti Srivastava, Amit Tyagi & Shweta Dang. (2020) Memantine nanoemulsion: a new approach to treat Alzheimer’s disease. Journal of Microencapsulation 37:5, pages 355-365.
Read now
Madeleine S. A. Tan, Harendra S Parekh, Preeti Pandey, Dan J. Siskind & James R. Falconer. (2020) Nose-to-brain delivery of antipsychotics using nanotechnology: a review. Expert Opinion on Drug Delivery 17:6, pages 839-853.
Read now
Rubin Hao, Bixi Sun, Lihua Yang, Chun Ma & Shuling Li. (2020) RVG29-modified microRNA-loaded nanoparticles improve ischemic brain injury by nasal delivery. Drug Delivery 27:1, pages 772-781.
Read now
Saleha Rehman, Bushra Nabi, Ameeduzzafar Zafar, Sanjula Baboota & Javed Ali. (2019) Intranasal delivery of mucoadhesive nanocarriers: a viable option for Parkinson’s disease treatment?. Expert Opinion on Drug Delivery 16:12, pages 1355-1366.
Read now
Rajalakshmi Rukmangathen, Indira Muzib Yallamalli & Prasanna Raju Yalavarthi. (2019) Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery. Drug Development and Industrial Pharmacy 45:8, pages 1342-1350.
Read now
Pooja Keshari, Yogesh Sonar & Hitendra Mahajan. (2019) Curcumin loaded TPGS micelles for nose to brain drug delivery: in vitro and in vivo studies. Materials Technology 34:7, pages 423-432.
Read now
Ebtsam M. Abdou, Soha M. Kandil, Amany Morsi & Maysa W. Sleem. (2019) In-vitro and in-vivo respiratory deposition of a developed metered dose inhaler formulation of an anti-migraine drug. Drug Delivery 26:1, pages 689-699.
Read now
Kousalya Selvaraj, Kuppusamy Gowthamarajan & Veera Venkata Satyanarayana Reddy Karri. (2018) Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting. Artificial Cells, Nanomedicine, and Biotechnology 46:8, pages 2088-2095.
Read now
Luigi Battaglia, Pier Paolo Panciani, Elisabetta Muntoni, Maria Teresa Capucchio, Elena Biasibetti, Pasquale De Bonis, Silvia Mioletti, Marco Fontanella & Shankar Swaminathan. (2018) Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery. Expert Opinion on Drug Delivery 15:4, pages 369-378.
Read now
Niyaz Ahmad. (2017) Rasagiline-encapsulated chitosan-coated PLGA nanoparticles targeted to the brain in the treatment of parkinson's disease. Journal of Liquid Chromatography & Related Technologies 40:13, pages 677-690.
Read now
Dan Zheng, Xiao Shuai, Yanping Li, Peng Zhou, Tao Gong, Xun Sun & Zhirong Zhang. (2016) Novel flurbiprofen derivatives with improved brain delivery: synthesis, in vitro and in vivo evaluations. Drug Delivery 23:7, pages 2183-2192.
Read now
Angel Treasa Alex, Alex Joseph, Gopal Shavi, Josyula Venkata Rao & Nayanabhirama Udupa. (2016) Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery. Drug Delivery 23:7, pages 2144-2153.
Read now
Yan Wei, Mingzhen Ying, Shuai Xu, Feng Wang, Aifeng Zou, Shilei Cao, Xinguo Jiang & Yajie Wang. (2016) Microdialysis pharmacokinetic study of scopolamine in plasma, olfactory bulb and vestibule after intranasal administration. Drug Delivery 23:1, pages 263-268.
Read now
Deepti Mittal, Shadab Md, Quamrul Hasan, Mohammad Fazil, Asgar Ali, Sanjula Baboota & Javed Ali. (2016) Brain targeted nanoparticulate drug delivery system of rasagiline via intranasal route. Drug Delivery 23:1, pages 130-139.
Read now
Bruno Fonseca-Santos, Maria Palmira Daflon Gremião & Marlus Chorilli. (2015) Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease. International Journal of Nanomedicine 10, pages 4981-5003.
Read now
Shadab Md, Gulam Mustafa, Sanjula Baboota & Javed Ali. (2015) Nanoneurotherapeutics approach intended for direct nose to brain delivery. Drug Development and Industrial Pharmacy 41:12, pages 1922-1934.
Read now
Guilherme J. M. Garcia, Jeffry D. Schroeter & Julia S. Kimbell. (2015) Olfactory deposition of inhaled nanoparticles in humans. Inhalation Toxicology 27:8, pages 394-403.
Read now
Xiang Wang, Ping Liu, Weixiao Yang, Lu Li, Peijing Li, Zheng Liu, Zhongxiong Zhuo & Yunhua Gao. (2014) Microbubbles coupled to methotrexate-loaded liposomes for ultrasound-mediated delivery of methotrexate across the blood–brain barrier. International Journal of Nanomedicine 9, pages 4899-4909.
Read now

Articles from other publishers (190)

Sagar Trivedi, Suraj Kause & Veena Belgamwar. (2023) Intranasal delivery of poly (d-glucosamine) encrusted self-assembled lipidic nanovesicles to enhanced brain uptake of thymoquinone for management of Glioblastoma Multiforme. Journal of Drug Delivery Science and Technology 90, pages 105149.
Crossref
Dhananjay Bhatane, Sharon Rose Pamshong, Santosh Sarnaik, Prabakaran A & Amit Alexander. (2023) Potential applications of mesoporous silica nanoparticles for the treatment of neurological disorders. Journal of Drug Delivery Science and Technology 89, pages 104970.
Crossref
Muhammad Ahsan Waqar, Muhammad Zaman, Huma Hameed, Muhammad Jamshaid, Ali Irfan, Gamal A. Shazly, Ana Cláudia Paiva-Santos & Yousef A. Bin Jardan. (2023) Formulation, Characterization, and Evaluation of β-Cyclodextrin Functionalized Hypericin Loaded Nanocarriers. ACS Omega 8:41, pages 38191-38203.
Crossref
Yujia Zheng, Xiaolu Zhang, Ruifeng Zhang, Ziyu Wang, Jiali Gan, Qing Gao, Lin Yang, Pengjuan Xu & Xijuan Jiang. (2023) Inflammatory signaling pathways in the treatment of Alzheimer's disease with inhibitors, natural products and metabolites (Review). International Journal of Molecular Medicine 52:5.
Crossref
Krushna Shirsath & Yogeeta O. Agrawal. (2023) A Potential Strategy for Treating Parkinson's Disease Through Intranasal Nanoemulsions. CNS & Neurological Disorders - Drug Targets 22:8, pages 1137-1145.
Crossref
AMRUTA SONAWANE, GAYATRI JAWALE, NITIN DEVHADRAO, ASHWINI BANSODE, JYOTI LOKHANDE, DHANASHREE KHERADE, PRATIKSHA SATHE, NITIN DESHMUKH, GANESH DAMA & HARSHAL TARE. (2023) FORMULATION AND DEVELOPMENT OF MUCOADHESIVE NASAL DRUG DELIVERY OF ROPINIROL HCL FOR BRAIN TARGETING. International Journal of Applied Pharmaceutics, pages 325-332.
Crossref
Garima Rai, Pammi Gauba & Shweta Dang. (2023) Recent advances in nanotechnology for Intra-nasal drug delivery and clinical applications. Journal of Drug Delivery Science and Technology 86, pages 104726.
Crossref
Chun Yuen Jerry Wong, Alberto Baldelli, Hanieh Gholizadeh, Hale Oguzlu, Yigong Guo, Hui Xin Ong, Athenea Pascual Rodriguez, Gurpreet Singhera, Andrew Thamboo, Anika Singh, Anubhav Pratap-Singh & Daniela Traini. (2023) Engineered dry powders for the nose-to-brain delivery of transforming growth factor-beta. European Journal of Pharmaceutics and Biopharmaceutics 189, pages 202-211.
Crossref
Mohammad, Urooj Ahmed Khan, Zoya Saifi, Jinku Bora, Musarrat Husain Warsi, Mohammed A. S. Abourehab, Gaurav Kumar Jain, Prashant Kesharwani & Asgar Ali. (2023) Intranasal inorganic cerium oxide nanoparticles ameliorate oxidative stress induced motor manifestations in haloperidol-induced parkinsonism. Inflammopharmacology.
Crossref
Fereshte Mohamadi Gharaghani, Sara Mostafapour & Bahram Hemmateenejad. (2023) A Paper-Based Biomimetic Sensing Device for the Discrimination of Original and Fraudulent Cigarette Brands Using Mixtures of MoS2 Quantum Dots and Organic Dyes. Biosensors 13:7, pages 705.
Crossref
Shuxia Yao, Yuanshu Chen, Qian Zhuang, Yingying Zhang, Chunmei Lan, Siyu Zhu, Benjamin Becker & Keith M. Kendrick. (2023) Sniffing oxytocin: Nose to brain or nose to blood?. Molecular Psychiatry 28:7, pages 3083-3091.
Crossref
Bruno Fonseca-Santos, Camila André Cazarin, Patrícia Bento da Silva, Kaio Pini dos Santos, Márcia Cristina Oliveira da Rocha, Sônia Nair Báo, Márcia Maria De-Souza & Marlus Chorilli. (2023) Intranasal in situ gelling liquid crystal for delivery of resveratrol ameliorates memory and neuroinflammation in Alzheimer's disease. Nanomedicine: Nanotechnology, Biology and Medicine 51, pages 102689.
Crossref
Seoyeon Won, Jeongyeon An, Hwayoung Song, Subin Im, Geunho You, Seungho Lee, Kyo-in Koo & Chang Ho Hwang. (2023) Transnasal targeted delivery of therapeutics in central nervous system diseases: a narrative review. Frontiers in Neuroscience 17.
Crossref
Hasham Shafi, Rumaisa Rashid, Sami-ullah Rather, D.V. Siva Reddy, Lubna Azmi, Abdalla Abdal-hay, Salman H. Alrokayan, Haseeb A Khan, Nisar Ahmad Khan & Faheem A. Sheikh. (2023) Super disintegrating oromucosal nanofiber patch of zolmitriptan for rapid delivery and efficient brain targeting. Chemical Engineering Journal 463, pages 142481.
Crossref
Xiyue He, Xiaoyan Chen, Hairui Wang, Guangsheng Du & Xun Sun. (2023) Recent advances in respiratory immunization: A focus on COVID-19 vaccines. Journal of Controlled Release 355, pages 655-674.
Crossref
Sachin S. Gaikwad, Snehal R. Pathare, Mayur A. More, Nikita A. Waykhinde, Umesh D. Laddha, Kishor S. Salunkhe, Sanjay J. Kshirsagar, Sakshi S. Patil & Kuldeep H. Ramteke. (2023) Dry Powder Inhaler with the technical and practical obstacles, and forthcoming platform strategies. Journal of Controlled Release 355, pages 292-311.
Crossref
Chaemin Lim, Jain Koo & Kyung Taek Oh. (2022) Nanomedicine approaches for medulloblastoma therapy. Journal of Pharmaceutical Investigation 53:2, pages 213-233.
Crossref
Satoshi Deyama, Shun Aoki, Rinako Sugie, Hayato Fukuda, Satoshi Shuto, Masabumi Minami & Katsuyuki Kaneda. (2023) Intranasal Administration of Resolvin E1 Produces Antidepressant-Like Effects via BDNF/VEGF-mTORC1 Signaling in the Medial Prefrontal Cortex. Neurotherapeutics 20:2, pages 484-501.
Crossref
Elena Marcello & Valeria Chiono. (2023) Biomaterials-Enhanced Intranasal Delivery of Drugs as a Direct Route for Brain Targeting. International Journal of Molecular Sciences 24:4, pages 3390.
Crossref
Vidhi Tanna, Sujata P. Sawarkar & Padmini Ravikumar. (2023) Exploring Nose to Brain Nano Delivery for Effective Management of Migraine. Current Drug Delivery 20:2, pages 144-157.
Crossref
Puja Sandbhor, Jayant Goda, Bhabani Mohanty, Poonam Gera, Sandhya Yadav, Godanjali Chekuri, Pradip Chaudhari, Shilpee Dutt & Rinti Banerjee. (2022) Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model. Drug Delivery and Translational Research 13:2, pages 608-626.
Crossref
Anja Haasbroek‐Pheiffer, Suzanne Van Niekerk, Frank Van der Kooy, Theunis Cloete, Jan Steenekamp & Josias Hamman. (2023) In vitro and ex vivo experimental models for evaluation of intranasal systemic drug delivery as well as direct nose‐to‐brain drug delivery . Biopharmaceutics & Drug Disposition 44:1, pages 94-112.
Crossref
Li Du, Lin Chen, Fangfang Liu, Wenya Wang & Hongyun Huang. 2023. Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors. Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors 255 297 .
Jason T. Duskey, Alexander B. Cook, Gabriella Costabile, Giovanni Tosi & Michele Schlich. 2023. New Insights Into Glioblastoma. New Insights Into Glioblastoma 405 434 .
Mohamed Fawzi Kabil, Zeinab A. Mohamed, Kholoud Arafa & Ibrahim M. El-Sherbiny. 2023. Advanced and Modern Approaches for Drug Delivery. Advanced and Modern Approaches for Drug Delivery 259 279 .
Paul D. Dalton, Kelly L. O'Neill, Ana Paula Pêgo, Giles W. Plant, David R. Nisbet, Martin Oudega, Gary A. Brook & Alan R. Harvey. 2023. Tissue Engineering. Tissue Engineering 585 627 .
Lisa Feldman & Behnam Badie. 2023. NK Cells in Cancer Immunotherapy: Successes and Challenges. NK Cells in Cancer Immunotherapy: Successes and Challenges 263 280 .
Thi Hong Nhung Vu, Svetlana Morozkina, Petr Snetkov & Mayya Uspenskaya. 2023. Nano- and Microfabrication Techniques in Drug Delivery. Nano- and Microfabrication Techniques in Drug Delivery 429 466 .
Muhammad Sarfraz, Sara Mousa, Ranim Al Saoud & Raimar Löbenberg. 2023. Nasal Drug Delivery. Nasal Drug Delivery 339 360 .
Mahmoud Gharbavi, Sepideh Parvanian, Milad Parvinzad Leilan, Shabnam Tavangar, Maedeh Parchianlou & Ali Sharafi. 2023. Nasal Drug Delivery. Nasal Drug Delivery 279 324 .
Sherry Sharma, Jai Bharti Sharma, Shailendra Bhatt & Manish Kumar. (2022) Optimization and Fabrication of Curcumin Loaded Solid Lipid Nanoparticles Using Box-Behnken Design for Nasal Delivery. Nanoscience & Nanotechnology-Asia 12:6.
Crossref
Roshani R. Pagar & Meghraj V. Suryawanshi. (2022) A SYSTEMATIC OVERVIEW ON NOSE TO BRAIN DRUG DELIVERY SYSTEM IN TREATMENT OF NEURODEGENERATIVE DISORDERS. Indian Drugs 59:11, pages 7-14.
Crossref
Elodie Passeri, Kamil Elkhoury, Margaretha Morsink, Kerensa Broersen, Michel Linder, Ali Tamayol, Catherine Malaplate, Frances T. Yen & Elmira Arab-Tehrany. (2022) Alzheimer’s Disease: Treatment Strategies and Their Limitations. International Journal of Molecular Sciences 23:22, pages 13954.
Crossref
Aravind Shyamprasad Rekharani, Bala Sai Soujith NidamanuriPraharsh Kumar Mandadhi RajendraSenthil VenkatachalamJubie SelvarajJawahar Natarajan. (2022) Formulation, Optimization and Characterization of Bupropion Hydrochloride Loaded Nanostructured Lipid Carriers for Intra-Nasal Administration: An Approach to Management of Smoking Cessation. Current Nanomedicine 12:3, pages 217-232.
Crossref
Francisco J. Padilla-Godínez, Leonardo I. Ruiz-Ortega & Magdalena Guerra-Crespo. (2022) Nanomedicine in the Face of Parkinson’s Disease: From Drug Delivery Systems to Nanozymes. Cells 11:21, pages 3445.
Crossref
A.C. Correia, A.R. Monteiro, R. Silva, J.N. Moreira, J.M. Sousa Lobo & A.C. Silva. (2022) Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood–brain barrier (BBB) to manage neurological disorders. Advanced Drug Delivery Reviews 189, pages 114485.
Crossref
Kimberly W. Y. Mak, Aws F. Mustafa & Denise D. Belsham. (2022) Neuroendocrine microRNAs linked to energy homeostasis: future therapeutic potential. Pharmacological Reports 74:5, pages 774-789.
Crossref
Zhiyu Jin, Yu Han, Danshen Zhang, Zhongqiu Li, Yongshuai Jing, Beibei Hu & Shiguo Sun. (2022) Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients. Pharmaceutics 14:10, pages 2070.
Crossref
K. Trideva Sastri, N. Vishal Gupta, Sharadha M, Souvik Chakraborty, Hitesh Kumar, Pallavi Chand, V. Balamuralidhara & D.V. Gowda. (2022) Nanocarrier facilitated drug delivery to the brain through intranasal route: A promising approach to transcend bio-obstacles and alleviate neurodegenerative conditions. Journal of Drug Delivery Science and Technology 75, pages 103656.
Crossref
Moran Haim Zada, Yakir Rottenberg & Abraham J. Domb. (2022) Peptide loaded polymeric nanoparticles by non-aqueous nanoprecipitation. Journal of Colloid and Interface Science 622, pages 904-913.
Crossref
Marina A. Bekhet, Adel A. Ali, Rasha M. Kharshoum, Fatma I. Abo El-Ela & Heba F. Salem. (2022) Intranasal Niosomal In Situ Gel As A Novel Strategy for Improving Citicoline Efficacy and Brain Delivery in Treatment of Epilepsy: In Vitro and Ex Vivo Characterization and In Vivo Pharmacodynamics Investigation. Journal of Pharmaceutical Sciences 111:8, pages 2258-2269.
Crossref
Caitlyn J. Finton & Alexander G. Ophir. (2022) Developmental exposure to intranasal vasopressin impacts adult prairie vole spatial memory. Psychoneuroendocrinology 141, pages 105750.
Crossref
Wei-Lin Lo, Ya-Han Wang, Eric H-L Chen, Shih-Min Wang, Liang-Chen Chen & Rita P-Y Chen. (2022) Biodistribution analysis of an intranasal-delivered peptide by the nanoSPECT/CT imaging. Journal of Drug Delivery Science and Technology 73, pages 103454.
Crossref
Mohammad Zaki Ahmad, Javed Ahmad, Mohammed Yahia Alasmary, Sohail Akhter, Mohammed Aslam, Kalyani Pathak, Parween Jamil & M.M. Abdullah. (2022) Nanoemulgel as an approach to improve the biopharmaceutical performance of lipophilic drugs: Contemporary research and application. Journal of Drug Delivery Science and Technology 72, pages 103420.
Crossref
Elisabetta Muntoni, Elisabetta Marini, Chiara Ferraris, Sara Garelli, Maria Teresa Capucchio, Elena Colombino, Pier Paolo Panciani & Luigi Battaglia. (2022) Intranasal lipid nanocarriers: Uptake studies with fluorescently labeled formulations. Colloids and Surfaces B: Biointerfaces 214, pages 112470.
Crossref
Junhu Tai, Munsoo Han, Dabin Lee, Il-Ho Park, Sang Hag Lee & Tae Hoon Kim. (2022) Different Methods and Formulations of Drugs and Vaccines for Nasal Administration. Pharmaceutics 14:5, pages 1073.
Crossref
Daniel E. Morales & Shaker Mousa. (2022) Intranasal delivery in glioblastoma treatment: prospective molecular treatment modalities. Heliyon 8:5, pages e09517.
Crossref
Mohammed A.S. Abourehab, Mohammad Javed Ansari, Anshul Singh, Ahmed Hassan, Mohamed A. Abdelgawad, Prachi Shrivastav, Bassam M. Abualsoud, Larissa Souza Amaral & Sheersha Pramanik. (2022) Cubosomes as an emerging platform for drug delivery: a review of the state of the art. Journal of Materials Chemistry B 10:15, pages 2781-2819.
Crossref
Sunena Jha & Dinanath Mishra. (2022) Evaluation of Brain Targeting Potential of Zolmitriptan Mucoadhesive Nanoparticles for Intranasal Drug Delivery. Pharmaceutical Nanotechnology 10:2, pages 113-124.
Crossref
Mireya L. Borrajo & María José Alonso. (2021) Using nanotechnology to deliver biomolecules from nose to brain — peptides, proteins, monoclonal antibodies and RNA. Drug Delivery and Translational Research 12:4, pages 862-880.
Crossref
Kamalesh Tripathi & Niranjan K. Manna. (2022) Enhanced Brain Uptake and Behaviour Study of Buspirone Loaded in situ Nanoemulsion Gel. International Journal of Pharmacology 18:3, pages 543-550.
Crossref
Gábor Katona, Fakhara Sabir, Bence Sipos, Muhammad Naveed, Zsuzsanna Schelz, István Zupkó & Ildikó Csóka. (2022) Development of Lomustine and n-Propyl Gallate Co-Encapsulated Liposomes for Targeting Glioblastoma Multiforme via Intranasal Administration. Pharmaceutics 14:3, pages 631.
Crossref
Hadel A. Abo El-Enin, Rasha E. Mostafa, Marwa F. Ahmed, Ibrahim A. Naguib, Mohamed A. Abdelgawad, Mohammed M. Ghoneim & Ebtsam M. Abdou. (2022) Assessment of Nasal-Brain-Targeting Efficiency of New Developed Mucoadhesive Emulsomes Encapsulating an Anti-Migraine Drug for Effective Treatment of One of the Major Psychiatric Disorders Symptoms. Pharmaceutics 14:2, pages 410.
Crossref
Chandrakantsing V. Pardeshi, Mayank Handa & Rahul Shukla. 2022. Nanoengineering of Biomaterials. Nanoengineering of Biomaterials 261 307 .
Amarjitsing Rajput & Shital Butani. (2022) Donepezil HCl Liposomes: Development, Characterization, Cytotoxicity, and Pharmacokinetic Study. AAPS PharmSciTech 23:2.
Crossref
Marwa Eid Sayyed, Mohamed Abd El-Motaleb, Ismail Taha Ibrahim, Hassan Medhat Rashed, Mohamed Ahmed El-Nabarawi & Mohamed Abdallah Ahmed. (2022) Preparation, characterization, and in vivo biodistribution study of intranasal 131I-clonazepam-loaded phospholipid magnesome as a promising brain delivery system. European Journal of Pharmaceutical Sciences 169, pages 106089.
Crossref
Shuxia Yao & Keith Maurice Kendrick. (2022) Effects of Intranasal Administration of Oxytocin and Vasopressin on Social Cognition and Potential Routes and Mechanisms of Action. Pharmaceutics 14:2, pages 323.
Crossref
Fakhara Sabir, Qurrat Ul Ain, Abbas Rahdar, Zhugen Yang, Mahmood Barani, Mauhammad Bilal & Nikhil Bhalla. 2022. Synthesis and Applications of Nanoparticles. Synthesis and Applications of Nanoparticles 455 485 .
Haihong Zhou, Furong Sun, Mingqian Ou, Yu Zhang, Meijun Lin, Liqin Song, Yangsheng Yu, Haojie Liao, Weihao Fan, Huaijie Xing, Minhua Li, Kui Zhao, Xiaolian Wu, Yuanhong Sun, Chunmei Liang, Yujie Cai & Lili Cui. (2021) Prior nasal delivery of antagomiR-122 prevents radiation-induced brain injury. Molecular Therapy 29:12, pages 3465-3483.
Crossref
Helena Domin. (2021) Neuropeptide Y Y2 and Y5 receptors as potential targets for neuroprotective and antidepressant therapies: Evidence from preclinical studies. Progress in Neuro-Psychopharmacology and Biological Psychiatry 111, pages 110349.
Crossref
David Lee & Tamara Minko. (2021) Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier. Pharmaceutics 13:12, pages 2049.
Crossref
N. N. Porfiryeva, I. I. Semina, R. I. Moustafine & V. V. Khutoryanskiy. (2021) Intranasal Administration as a Route to Deliver Drugs to the Brain (Review). Drug development & registration 10:4, pages 117-127.
Crossref
Brijesh Shah. (2021) Microemulsion as a promising carrier for nose to brain delivery: journey since last decade. Journal of Pharmaceutical Investigation 51:6, pages 611-634.
Crossref
Magalie Fréchou, Xiaoyan Zhu, Narender Kumar, Regine Sitruk-Ware, Michael Schumacher, Claudia Mattern & Rachida Guennoun. (2021) Sex differences in the cerebroprotection by Nestorone intranasal delivery following stroke in mice. Neuropharmacology 198, pages 108760.
Crossref
Nasr A. Emad, Bakr Ahmed, Abdulsalam Alhalmi, Nafaa Alzobaidi & Sana Saleh Al-Kubati. (2021) Recent progress in nanocarriers for direct nose to brain drug delivery. Journal of Drug Delivery Science and Technology 64, pages 102642.
Crossref
Hetal P. Patel, Priyanshi A. Gandhi, Priyanka S. Chaudhari, Bhargavi V. Desai, Ditixa T. Desai, Praful P. Dedhiya, Furqan A. Maulvi & Bhavin A. Vyas. (2021) Clozapine loaded nanostructured lipid carriers engineered for brain targeting via nose-to-brain delivery: Optimization and in vivo pharmacokinetic studies. Journal of Drug Delivery Science and Technology 64, pages 102533.
Crossref
Dipy M. Vasa, Zainab Bakri, Maureen D. Donovan, Lauren A. O’Donnell & Peter L. D. Wildfong. (2021) Evaluation of Ribavirin–Poloxamer Microparticles for Improved Intranasal Absorption. Pharmaceutics 13:8, pages 1126.
Crossref
Shubham Musale & Prabhanjan Giram. (2021) NOSE TO BRAIN DELIVERY: ROLE OF VIRAL AND NON-VIRAL VECTORS FOR NEUROLOGICAL DISORDER. Indian Drugs 58:05, pages 7-20.
Crossref
Raju Saka, Naveen Chella & Wahid Khan. (2021) Development of Imatinib Mesylate-Loaded Liposomes for Nose to Brain Delivery: In Vitro and In Vivo Evaluation. AAPS PharmSciTech 22:5.
Crossref
Hussein Akel, Ruba Ismail, Gábor Katona, Fakhara Sabir, Rita Ambrus & Ildikó Csóka. (2021) A comparison study of lipid and polymeric nanoparticles in the nasal delivery of meloxicam: Formulation, characterization, and in vitro evaluation. International Journal of Pharmaceutics 604, pages 120724.
Crossref
Robert F. Phalen, Mark D. Hoover, Michael J. Oldham & Annie M. Jarabek. (2021) Inhaled aerosol dosimetry: Research-related needs and recommendations. Journal of Aerosol Science 155, pages 105755.
Crossref
Natália N. Ferreira, Edilson de Oliveira Junior, Sara Granja, Fernanda I. Boni, Leonardo M.B. Ferreira, Beatriz S.F. Cury, Lilian C.R. Santos, Rui M. Reis, Eliana M. Lima, Fátima Baltazar & Maria Palmira D. Gremião. (2021) Nose-to-brain co-delivery of drugs for glioblastoma treatment using nanostructured system. International Journal of Pharmaceutics 603, pages 120714.
Crossref
Chandra Teja Uppuluri, Punna Rao Ravi, Avantika V. Dalvi, Shafik Shakil Shaikh & Suvarna R. Kale. (2020) Piribedil loaded thermo-responsive nasal in situ gelling system for enhanced delivery to the brain: formulation optimization, physical characterization, and in vitro and in vivo evaluation. Drug Delivery and Translational Research 11:3, pages 909-926.
Crossref
Cecília de Barros, Norberto Aranha, Patrícia Severino, Eliana B. Souto, Aleksandra Zielińska, André Lopes, Alessandra Rios, Fernando Batain, Kessi Crescencio, Marco Chaud & Thais Alves. (2021) Quality by Design Approach for the Development of Liposome Carrying Ghrelin for Intranasal Administration. Pharmaceutics 13:5, pages 686.
Crossref
Jennifer M. Erichsen, Coleman B. Calva, Lawrence P. Reagan & Jim R. Fadel. (2021) Intranasal insulin and orexins to treat age-related cognitive decline. Physiology & Behavior 234, pages 113370.
Crossref
Hetal P. Patel, Priyanka S. Chaudhari, Priyanshi A. Gandhi, Bhargavi V. Desai, Ditixa T. Desai, Praful P. Dedhiya, Bhavin A. Vyas & Furqan A. Maulvi. (2021) Nose to brain delivery of tailored clozapine nanosuspension stabilized using (+)-alpha-tocopherol polyethylene glycol 1000 succinate: Optimization and in vivo pharmacokinetic studies. International Journal of Pharmaceutics 600, pages 120474.
Crossref
Mohammed A. S. Abourehab, Ahmed Khames, Samar Genedy, Shahin Mostafa, Mohammad A. Khaleel, Mahmoud M. Omar & Amani M. El Sisi. (2021) Sesame Oil-Based Nanostructured Lipid Carriers of Nicergoline, Intranasal Delivery System for Brain Targeting of Synergistic Cerebrovascular Protection. Pharmaceutics 13:4, pages 581.
Crossref
Roberta Cassano, Camilla Servidio & Sonia Trombino. (2021) Biomaterials for Drugs Nose–Brain Transport: A New Therapeutic Approach for Neurological Diseases. Materials 14:7, pages 1802.
Crossref
Hetal Thakkar, Darshan Vaghela & Brijesh Pradipkumar Patel. (2021) Brain targeted intranasal in-situ gelling spray of paroxetine: Formulation, characterization and in-vivo evaluation". Journal of Drug Delivery Science and Technology 62, pages 102317.
Crossref
Cláudia Pina Costa, João Nuno Moreira, José Manuel Sousa Lobo & Ana Catarina Silva. (2021) Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies. Acta Pharmaceutica Sinica B 11:4, pages 925-940.
Crossref
Leonor C. Fonseca, João A. Lopes, João Vieira, Cláudia Viegas, Cláudia S. Oliveira, Rafael P. Hartmann & Pedro Fonte. (2021) Intranasal drug delivery for treatment of Alzheimer’s disease. Drug Delivery and Translational Research 11:2, pages 411-425.
Crossref
Marios Charalambous, Holger A. Volk, Luc Van Ham & Sofie F. M. Bhatti. (2021) First-line management of canine status epilepticus at home and in hospital-opportunities and limitations of the various administration routes of benzodiazepines. BMC Veterinary Research 17:1.
Crossref
Raheleh Gholamzadeh, Nahid Aboutaleb & Donya Nazarinia. (2021) Intravenous injection of apelin-13 improves sensory-motor balance deficits caused by cerebral ischemic reperfusion injury in male wistar rats via restoration of nitric oxide. Journal of Chemical Neuroanatomy 112, pages 101886.
Crossref
Avantika V. Dalvi, Punna R. Ravi, Chandra T. Uppuluri, Radhika R. Mahajan, Sumeet V. Katke & Vibha S. Deshpande. (2021) Thermosensitive nasal in situ gelling systems of rufinamide formulated using modified tamarind seed xyloglucan for direct nose-to-brain delivery: design, physical characterization, and in vivo evaluation. Journal of Pharmaceutical Investigation 51:2, pages 199-211.
Crossref
Jessica Hersh, David Broyles, José Manuel Condor Capcha, Emre Dikici, Lina A. Shehadeh, Sylvia Daunert & Sapna Deo. (2020) Peptide-Modified Biopolymers for Biomedical Applications. ACS Applied Bio Materials 4:1, pages 229-251.
Crossref
爱林 邓. (2021) Nanoparticles Administered through Nasal Cavity and Its Progress in the Treatment of Brain Diseases. Hans Journal of Biomedicine 11:02, pages 69-74.
Crossref
Veena S. Belgamwar, Vidyadevi T. Bhoyar, Sagar Trivedi & Chandrakantsing V. Pardeshi. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery 459 481 .
Abhijeet Kulkarni, Mahesh Shinde, Gaurav Sonawane, Hitesh Raotole, Rohit Pande & Chandrakantsing V. Pardeshi. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery 329 349 .
Ganesh B. Shevalkar, Mahendra K. Prajapati, Rohan V. Pai & Kamlesh D. Mali. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery 249 266 .
Farrukh Zeeshan, Dinesh Kumar Mishra & Prashant Kesharwani. 2021. Theory and Applications of Nonparenteral Nanomedicines. Theory and Applications of Nonparenteral Nanomedicines 153 180 .
Lucrezia Spadera, Pasquale Viola, Davide Pisani, Alfonso Scarpa, Donatella Malanga, Gerardo Sorrentino, Enrico Madini, Carla Laria, Teodoro Aragona, Gianluca Leopardi, Giandomenico Maggiore, Marco Ciriolo, Luigi Boccuto, Raffaella Pizzolato, Ludovico Abenavoli, Claudia Cassandro, Massimo Ralli, Ettore Cassandro & Giuseppe Chiarella. (2020) Sudden olfactory loss as an early marker of COVID-19: a nationwide Italian survey. European Archives of Oto-Rhino-Laryngology 278:1, pages 247-255.
Crossref
Brijesh Patel & Hetal P. Thakkar. 2021. Nanocarriers: Drug Delivery System. Nanocarriers: Drug Delivery System 227 254 .
Mugdha Agarwal, Mohammad Rizwan Alam, Mohd Kabir Haider, Md. Zubbair Malik & Dae-Kwang Kim. (2020) Alzheimer’s Disease: An Overview of Major Hypotheses and Therapeutic Options in Nanotechnology. Nanomaterials 11:1, pages 59.
Crossref
Shiv Bahadur, Dinesh M. Pardhi, Jarkko Rautio, Jessica M. Rosenholm & Kamla Pathak. (2020) Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders. Pharmaceutics 12:12, pages 1230.
Crossref
Anupam Sarma & Malay K. Das. (2020) Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS. Molecular Biomedicine 1:1.
Crossref
Natália N. Ferreira, Sara Granja, Fernanda I. Boni, Fabíola G. Prezotti, Leonardo M. B. Ferreira, Beatriz S. F. Cury, Rui M. Reis, Fátima Baltazar & Maria Palmira D. Gremião. (2020) Modulating chitosan-PLGA nanoparticle properties to design a co-delivery platform for glioblastoma therapy intended for nose-to-brain route. Drug Delivery and Translational Research 10:6, pages 1729-1747.
Crossref
Edilson Ribeiro de Oliveira Junior, Lílian Cristina Rosa Santos, Mariana Arraes Salomão, Thais Leite Nascimento, Gerlon de Almeida Ribeiro Oliveira, Luciano Morais Lião & Eliana Martins Lima. (2020) Nose-to-brain drug delivery mediated by polymeric nanoparticles: influence of PEG surface coating. Drug Delivery and Translational Research 10:6, pages 1688-1699.
Crossref
Mukta Agrawal, Shailendra Saraf, Swarnlata Saraf, Sunil K. Dubey, Anu Puri, Umesh Gupta, Prashant Kesharwani, V. Ravichandiran, Pramod Kumar, V.G.M. Naidu, Upadhyayula Suryanarayana Murty, Ajazuddin & Amit Alexander. (2020) Stimuli-responsive In situ gelling system for nose-to-brain drug delivery. Journal of Controlled Release 327, pages 235-265.
Crossref
Bruno Fonseca-Santos & Marlus Chorilli. (2020) The uses of resveratrol for neurological diseases treatment and insights for nanotechnology based-drug delivery systems. International Journal of Pharmaceutics 589, pages 119832.
Crossref
Simone Ladel, Frank Maigler, Johannes Flamm, Patrick Schlossbauer, Alina Handl, Rebecca Hermann, Helena Herzog, Thomas Hummel, Boris Mizaikoff & Katharina Schindowski. (2020) Impact of Glycosylation and Species Origin on the Uptake and Permeation of IgGs through the Nasal Airway Mucosa. Pharmaceutics 12:11, pages 1014.
Crossref
Soma Sengupta, Shounak Sarkhel & Biswajit Mukherjee. (2020) Development and Characterization of Triple Action-Dental Mold. Current Dentistry 2:1, pages 60-69.
Crossref
Leon Newman, Artur Filipe Rodrigues, Dhifaf A. Jasim, Isabella Anna Vacchi, Cécilia Ménard-Moyon, Alberto Bianco, Cyrill Bussy & Kostas Kostarelos. (2020) Nose-to-Brain Translocation and Cerebral Biodegradation of Thin Graphene Oxide Nanosheets. Cell Reports Physical Science 1:9, pages 100176.
Crossref
Yu Long, Qiyue Yang, Yan Xiang, Yulu Zhang, Jinyan Wan, Songyu Liu, Nan Li & Wei Peng. (2020) Nose to brain drug delivery - A promising strategy for active components from herbal medicine for treating cerebral ischemia reperfusion. Pharmacological Research 159, pages 104795.
Crossref
Xiaoyu Chen, Jing Guo, Yunlong Huang, Shan Liu, Ying Huang, Zezhong Zhang, Fang Zhang, Zhongbing Lu, Fang Li, Jialin C. Zheng & Wenjun Ding. (2020) Urban airborne PM2.5-activated microglia mediate neurotoxicity through glutaminase-containing extracellular vesicles in olfactory bulb. Environmental Pollution 264, pages 114716.
Crossref
Cecilia T. de Barros, Alessandra C. Rios, Thaís F. R. Alves, Fernando Batain, Kessi M. M. Crescencio, Laura J. Lopes, Aleksandra Zielińska, Patricia Severino, Priscila G. Mazzola, Eliana B. Souto & Marco V. Chaud. (2020) Cachexia: Pathophysiology and Ghrelin Liposomes for Nose-to-Brain Delivery. International Journal of Molecular Sciences 21:17, pages 5974.
Crossref
Bruno Fonseca-Santos, Patrícia Bento Silva, Roberta Balansin Rigon, Mariana Rillo Sato & Marlus Chorilli. (2020) Formulating SLN and NLC as Innovative Drug Delivery Systems for Non-Invasive Routes of Drug Administration. Current Medicinal Chemistry 27:22, pages 3623-3656.
Crossref
Saurabh Mittal, Muhammad U. Ashhar, Farheen F. Qizilbash, Zufika Qamar, Jasjeet K. Narang, Shobhit Kumar, Javed Ali & Sanjula Baboota. (2020) Ligand Conjugated Targeted Nanotherapeutics for Treatment of Neurological Disorders. Current Pharmaceutical Design 26:19, pages 2291-2305.
Crossref
Shadab Md, Shahid Karim, Sanggetha R. Saker, Ooi A. Gie, Lim C. Hooi, Phua H. Yee, Alvin W.C. Kang, Chen K. Zhe, Ng Ian, Hibah M. Aldawsari, Khaled M. Hosny & Nabil A. Alhakamy. (2020) Current Status and Challenges in Rotigotine Delivery. Current Pharmaceutical Design 26:19, pages 2222-2232.
Crossref
Evgenia Mitsou, Vasiliki Pletsa, George T. Sotiroudis, Pierre Panine, Maria Zoumpanioti & Aristotelis Xenakis. (2020) Development of a microemulsion for encapsulation and delivery of gallic acid. The role of chitosan. Colloids and Surfaces B: Biointerfaces 190, pages 110974.
Crossref
Natália N. Ferreira, Sara Granja, Fernanda Isadora Boni, Leonardo M. B. Ferreira, Rui M. Reis, Fátima Baltazar & Maria Palmira D. Gremião. (2020) A novel strategy for glioblastoma treatment combining alpha-cyano-4-hydroxycinnamic acid with cetuximab using nanotechnology-based delivery systems. Drug Delivery and Translational Research 10:3, pages 594-609.
Crossref
Angela Bonaccorso, Maria Rosa Gigliobianco, Rosalia Pellitteri, Debora Santonocito, Claudia Carbone, Piera Di Martino, Giovanni Puglisi & Teresa Musumeci. (2020) Optimization of Curcumin Nanocrystals as Promising Strategy for Nose-to-Brain Delivery Application. Pharmaceutics 12:5, pages 476.
Crossref
Firoozeh Alavian & Nasrin Shams. (2020) Oral and Intra-nasal Administration of Nanoparticles in the Cerebral Ischemia Treatment in Animal Experiments: Considering its Advantages and Disadvantages. Current Clinical Pharmacology 15:1, pages 20-29.
Crossref
John Kealy, Chris Greene & Matthew Campbell. (2020) Blood-brain barrier regulation in psychiatric disorders. Neuroscience Letters 726, pages 133664.
Crossref
Archita Mallick, Archita Gupta, Afzal Hussain, Priyadarshi Aparajay, Sneha Singh, Sandeep Kumar Singh & Abhimanyu Dev. (2020) Intranasal delivery of gabapentin loaded optimized nanoemulsion for augmented permeation. Journal of Drug Delivery Science and Technology 56, pages 101606.
Crossref
Mahira Zeeshan, Mahwash Mukhtar, Qurat Ul Ain, Salman Khan & Hussain Ali. 2020. Pharmaceutical Formulation Design - Recent Practices. Pharmaceutical Formulation Design - Recent Practices.
Eugene P. Chung, Jennifer D. Cotter, Alesia V. Prakapenka, Rebecca L. Cook, Danielle M. DiPerna & Rachael W. Sirianni. (2020) Targeting Small Molecule Delivery to the Brain and Spinal Cord via Intranasal Administration of Rabies Virus Glycoprotein (RVG29)-Modified PLGA Nanoparticles. Pharmaceutics 12:2, pages 93.
Crossref
Toyofumi SUZUKI, Naoto SUZUKI & Takanori KANAZAWA. (2020) Transport Mechanism in the Nose-to-Brain Drug Delivery and Role of Nanosystems鼻から脳への薬物送達における輸送機構とナノシステムの役割. Oleoscience 20:2, pages 61-69.
Crossref
Stephen D. Silberstein, Stephen B. Shrewsbury & John Hoekman. (2019) Dihydroergotamine (DHE) – Then and Now: A Narrative Review. Headache: The Journal of Head and Face Pain 60:1, pages 40-57.
Crossref
Qianwen Wang, Tianjing Ren, Jiajia Zhao, Chun-Ho Wong, H.Y. Edwin Chan & Zhong Zuo. (2020) Exclusion of unsuitable CNS drug candidates based on their physicochemical properties and unbound fractions in biomatrices for brain microdialysis investigations. Journal of Pharmaceutical and Biomedical Analysis 178, pages 112946.
Crossref
Yan Xiang, Yu Long, Qiyue Yang, Chuan Zheng, Minquan Cui, Zhimin Ci, Xiumei Lv, Nan Li & Ruoqi Zhang. (2020) Pharmacokinetics, pharmacodynamics and toxicity of Baicalin liposome on cerebral ischemia reperfusion injury rats via intranasal administration. Brain Research 1726, pages 146503.
Crossref
Pratishtha, Samriddhi Srivastava & Swati Gupta. 2020. Nanoformulations in Human Health. Nanoformulations in Human Health 169 185 .
Lisa Feldman & Mike Chen. 2020. Cancer Regional Therapy. Cancer Regional Therapy 427 438 .
Niyaz Ahmad, Rizwan Ahmad, Md Aftab Alam, Farhan Jalees Ahmad & Rehan Abdur Rub. (2019) Quantification and Evaluation of Glycyrrhizic Acid-loaded Surface Decorated Nanoparticles by UHPLC-MS/MS and used in the Treatment of Cerebral Ischemia. Current Pharmaceutical Analysis 16:1, pages 24-39.
Crossref
Andi Dian Permana, Ismaiel A. Tekko, Maelíosa T.C. McCrudden, Qonita Kurnia Anjani, Delly Ramadon, Helen O. McCarthy & Ryan F. Donnelly. (2019) Solid lipid nanoparticle-based dissolving microneedles: A promising intradermal lymph targeting drug delivery system with potential for enhanced treatment of lymphatic filariasis. Journal of Controlled Release 316, pages 34-52.
Crossref
JinHong Jiang, Zhe Wang, XueYa Liang, YaoYan Nie, Xin Chang, HongXiang Xue, Shu Li & Chang Min. (2019) Intranasal MMI-0100 Attenuates Aβ1−42- and LPS-Induced Neuroinflammation and Memory Impairments via the MK2 Signaling Pathway. Frontiers in Immunology 10.
Crossref
Leslie A McCauliff, Annette Langan, Ran Li, Olga Ilnytska, Debosreeta Bose, Miriam Waghalter, Kimberly Lai, Peter C Kahn & Judith Storch. (2019) Intracellular cholesterol trafficking is dependent upon NPC2 interaction with lysobisphosphatidic acid. eLife 8.
Crossref
Giacovazzo, Bisogno, Piscitelli, Verde, Oddi, Maccarrone & Coccurello. (2019) Different Routes to Inhibit Fatty Acid Amide Hydrolase: Do All Roads Lead to the Same Place?. International Journal of Molecular Sciences 20:18, pages 4503.
Crossref
Davin Rautiola, Patricia D. Maglalang, Narsihmulu Cheryala, Kathryn M. Nelson, Gunda I. Georg, Jared M. Fine, Aleta L. Svitak, Katherine A. Faltesek, Leah R. Hanson, Usha Mishra, Lisa D. Coles, James C. Cloyd & Ronald A. Siegel. (2019) Intranasal Coadministration of a Diazepam Prodrug with a Converting Enzyme Results in Rapid Absorption of Diazepam in Rats. Journal of Pharmacology and Experimental Therapeutics 370:3, pages 796-805.
Crossref
Sunita Yadav, Grishma Pawar, Praveen Kulkarni, Craig Ferris & Mansoor Amiji. (2019) CNS Delivery and Anti-Inflammatory Effects of Intranasally Administered Cyclosporine-A in Cationic Nanoformulations. Journal of Pharmacology and Experimental Therapeutics 370:3, pages 843-854.
Crossref
Imrana Jazuli, Annu, Bushra Nabi, Thasleem moolakkadath, Tausif Alam, Sanjula Baboota & Javed Ali. (2019) Optimization of Nanostructured Lipid Carriers of Lurasidone Hydrochloride Using Box-Behnken Design for Brain Targeting: In Vitro and In Vivo Studies. Journal of Pharmaceutical Sciences 108:9, pages 3082-3090.
Crossref
Simone Ladel, Patrick Schlossbauer, Johannes Flamm, Harald Luksch, Boris Mizaikoff & Katharina Schindowski. (2019) Improved In Vitro Model for Intranasal Mucosal Drug Delivery: Primary Olfactory and Respiratory Epithelial Cells Compared with the Permanent Nasal Cell Line RPMI 2650. Pharmaceutics 11:8, pages 367.
Crossref
Ashwini Patel, Nazneen Surti & Ashok Mahajan. (2019) Intranasal drug delivery: Novel delivery route for effective management of neurological disorders. Journal of Drug Delivery Science and Technology 52, pages 130-137.
Crossref
Olatz Arteaga Cabeza, Alkisti Mikrogeorgiou, Sujatha Kannan & Donna M. Ferriero. (2019) Advanced nanotherapies to promote neuroregeneration in the injured newborn brain. Advanced Drug Delivery Reviews 148, pages 19-37.
Crossref
Sharmili Edwin Thanarajah, Sandra Iglesias, Bojana Kuzmanovic, Lionel Rigoux, Klaas E. Stephan, Jens C. Brüning & Marc Tittgemeyer. (2019) Modulation of midbrain neurocircuitry by intranasal insulin. NeuroImage 194, pages 120-127.
Crossref
Silvia Triarico, Palma Maurizi, Stefano Mastrangelo, Giorgio Attinà, Michele Antonio Capozza & Antonio Ruggiero. (2019) Improving the Brain Delivery of Chemotherapeutic Drugs in Childhood Brain Tumors. Cancers 11:6, pages 824.
Crossref
Gifty M. Jojo & Gowthamarajan Kuppusamy. (2019) Scope of new formulation approaches in the repurposing of pioglitazone for the management of Alzheimer’s disease. Journal of Clinical Pharmacy and Therapeutics 44:3, pages 337-348.
Crossref
Rui Li, Yuan Huang, Li Chen, Haihui Zhou, Mingwan Zhang, Lei Chang, Hong Shen, Meiling Zhou, Ping Su & Dongya Zhu. (2019) Targeted delivery of intranasally administered nanoparticles-mediated neuroprotective peptide NR2B9c to brain and neuron for treatment of ischemic stroke. Nanomedicine: Nanotechnology, Biology and Medicine 18, pages 380-390.
Crossref
Bappaditya Chatterjee, Bapi Gorain, Keithanchali Mohananaidu, Pinaki Sengupta, Uttam Kumar Mandal & Hira Choudhury. (2019) Targeted drug delivery to the brain via intranasal nanoemulsion: Available proof of concept and existing challenges. International Journal of Pharmaceutics 565, pages 258-268.
Crossref
Joana Gonçalves, Joana Bicker, Filipa Gouveia, Joana Liberal, Rui Caetano Oliveira, Gilberto Alves, Amílcar Falcão & Ana Fortuna. (2019) Nose-to-brain delivery of levetiracetam after intranasal administration to mice. International Journal of Pharmaceutics 564, pages 329-339.
Crossref
Shinji Iwasaki, Syunsuke Yamamoto, Noriyasu Sano, Kimio Tohyama, Yohei Kosugi, Atsutoshi Furuta, Teruki Hamada, Tomoko Igari, Yasushi Fujioka, Hideki Hirabayashi & Nobuyuki Amano. (2019) Direct Drug Delivery of Low-Permeable Compounds to the Central Nervous System Via Intranasal Administration in Rats and Monkeys. Pharmaceutical Research 36:5.
Crossref
Ekta Kadakia, Dean Bottino & Mansoor Amiji. (2019) Mathematical Modeling and Simulation to Investigate the CNS Transport Characteristics of Nanoemulsion-Based Drug Delivery Following Intranasal Administration. Pharmaceutical Research 36:5.
Crossref
Bettina Schwarz & Olivia M Merkel. (2019) Nose-to-brain delivery of biologics. Therapeutic Delivery 10:4, pages 207-210.
Crossref
M. E. Sayed, M. A. Motaleb, I. T. Ibrahim, G. A. S. Awad & R. O. Ahmed. (2018) Intranasal drug delivery of iodo-haloperidol as a radiopharmaceutical brain imaging agent. Journal of Radioanalytical and Nuclear Chemistry 319:3, pages 927-935.
Crossref
Franciele Bruinsmann, Stefania Pigana, Tanira Aguirre, Gabriele Souto, Gabriela Pereira, Annalisa Bianchera, Laura Fasiolo, Gaia Colombo, Magno Marques, Adriana Pohlmann, Silvia Guterres & Fabio Sonvico. (2019) Chitosan-Coated Nanoparticles: Effect of Chitosan Molecular Weight on Nasal Transmucosal Delivery. Pharmaceutics 11:2, pages 86.
Crossref
Rachida Guennoun, Magalie Fréchou, Pauline Gaignard, Philippe Liere, Abdelhamid Slama, Michael Schumacher, Christian Denier & Claudia Mattern. (2019) Intranasal administration of progesterone: A potential efficient route of delivery for cerebroprotection after acute brain injuries. Neuropharmacology 145, pages 283-291.
Crossref
Moran Haim Zada, Michael Kubek, Wahid Khan, Awanish Kumar & Abraham Domb. (2019) Dispersible hydrolytically sensitive nanoparticles for nasal delivery of thyrotropin releasing hormone (TRH). Journal of Controlled Release 295, pages 278-289.
Crossref
C. Costa, J.N. Moreira, M.H. Amaral, J.M. Sousa Lobo & A.C. Silva. (2019) Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis. Journal of Controlled Release 295, pages 187-200.
Crossref
Zi-Ying Wang, Sravan Gopalkrishnashetty Sreenivasmurthy, Ju-Xian Song, Jing-Yi Liu & Min Li. (2019) Strategies for brain-targeting liposomal delivery of small hydrophobic molecules in the treatment of neurodegenerative diseases. Drug Discovery Today 24:2, pages 595-605.
Crossref
J Aarthi Harini, Avineet Luthra, Shrey Madeka, Prasan Shankar, Pitchaiah Mandava, Ravishankar Pervaje, Sanjith Aaron & Archana Purushotham. (2019) Ayurvedic Treatment of Acute Ischemic Stroke: A Prospective Observational Study. Global Advances in Health and Medicine 8, pages 216495611984939.
Crossref
Archana Khosa, Ranendra Narayan Saha & Gautam Singhvi. 2019. Nanomaterials for Drug Delivery and Therapy. Nanomaterials for Drug Delivery and Therapy 461 514 .
Qingfeng Liu & Qizhi Zhang. 2019. Brain Targeted Drug Delivery System. Brain Targeted Drug Delivery System 219 239 .
Stephanie Andrade, Maria João Ramalho, Maria do Carmo Pereira & Joana A. Loureiro. (2018) Resveratrol Brain Delivery for Neurological Disorders Prevention and Treatment. Frontiers in Pharmacology 9.
Crossref
Karishma Khan, Mohd Aqil, Syed Sarim Imam, Abdul Ahad, Thasleem Moolakkadath, Yasmin Sultana & Mohd Mujeeb. (2018) Ursolic acid loaded intra nasal nano lipid vesicles for brain tumour: Formulation, optimization, in-vivo brain/plasma distribution study and histopathological assessment. Biomedicine & Pharmacotherapy 106, pages 1578-1585.
Crossref
Stella Gänger & Katharina Schindowski. (2018) Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa. Pharmaceutics 10:3, pages 116.
Crossref
Elka Touitou, Hiba Natsheh & Shaher Duchi. (2018) Buspirone Nanovesicular Nasal System for Non-Hormonal Hot Flushes Treatment. Pharmaceutics 10:3, pages 82.
Crossref
Vassilis Bourganis, Olga Kammona, Aleck Alexopoulos & Costas Kiparissides. (2018) Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics. European Journal of Pharmaceutics and Biopharmaceutics 128, pages 337-362.
Crossref
Archana Khosa, Satish Reddi & Ranendra N. Saha. (2018) Nanostructured lipid carriers for site-specific drug delivery. Biomedicine & Pharmacotherapy 103, pages 598-613.
Crossref
Douglas M. BennionU. Muscha Steckelings & Colin Sumners. (2018) Neuroprotection via AT2 receptor agonists in ischemic stroke. Clinical Science 132:10, pages 1055-1067.
Crossref
Blessing Aderibigbe. (2018) In Situ-Based Gels for Nose to Brain Delivery for the Treatment of Neurological Diseases. Pharmaceutics 10:2, pages 40.
Crossref
Douglas M. BennionChad H. JonesAlex N. DangJacob IsenbergJustin T. GrahamLena Lindblad, Oliver Domenig, Michael F. WatersMarko Poglitsch, Colin SumnersUlrike Muscha Steckelings. (2018) Protective effects of the angiotensin II AT2 receptor agonist compound 21 in ischemic stroke: a nose-to-brain delivery approach. Clinical Science 132:5, pages 581-593.
Crossref
Hiroki Tateiwa, Takashi Kawano, Atsushi Nishigaki, Daiki Yamanaka, Bun Aoyama, Marie Shigematsu-Locatelli, Satoru Eguchi, Fabricio M. Locatelli & Masataka Yokoyama. (2018) The role of hippocampal brain-derived neurotrophic factor in age-related differences in neuropathic pain behavior in rats. Life Sciences 197, pages 56-66.
Crossref
Shadab Md, Subrat K. Bhattmisra, Farrukh Zeeshan, Naiyer Shahzad, Md Ali Mujtaba, Venkata Srikanth Meka, Ammu Radhakrishnan, Prashant Kesharwani, Sanjula Baboota & Javed Ali. (2018) Nano-carrier enabled drug delivery systems for nose to brain targeting for the treatment of neurodegenerative disorders. Journal of Drug Delivery Science and Technology 43, pages 295-310.
Crossref
Qianwen Wang, Yufeng Zhang, Chun-Ho Wong, H.Y. Edwin Chan & Zhong Zuo. (2017) Demonstration of Direct Nose-to-Brain Transport of Unbound HIV-1 Replication Inhibitor DB213 Via Intranasal Administration by Pharmacokinetic Modeling. The AAPS Journal 20:1.
Crossref
Armaghan Emami, Jeff Tepper, Brian Short, Tony L. Yaksh, Alison M. Bendele, Thulasi Ramani, Alvaro F. Cisternas, Jay H. Chang & R. Daniel Mellon. (2017) Toxicology Evaluation of Drugs Administered via Uncommon Routes: Intranasal, Intraocular, Intrathecal/Intraspinal, and Intra-Articular. International Journal of Toxicology 37:1, pages 4-27.
Crossref
M.J. Santander-Ortega, M. Plaza-Oliver, V. Rodríguez-Robledo, L. Castro-Vázquez, N. Villaseca-González, J. González-Fuentes, P. Marcos, M.M. Arroyo-Jiménez & M.V. Lozano. (2017) Colloids for drug delivery to the brain. Journal of Drug Delivery Science and Technology 42, pages 193-206.
Crossref
Abdur Rauf Khan, Mengrui Liu, Muhammad Wasim Khan & Guangxi Zhai. (2017) Progress in brain targeting drug delivery system by nasal route. Journal of Controlled Release 268, pages 364-389.
Crossref
Carlos Javier Baier, Cristina Eugenia Gallegos, Rita Raisman-Vozari & Alejandra Minetti. (2017) Behavioral impairments following repeated intranasal glyphosate-based herbicide administration in mice. Neurotoxicology and Teratology 64, pages 63-72.
Crossref
Qian Zhang, Mengbi Yang, Kasper K. Sørensen, Charlotte S. Madsen, Josephine T. Boesen, Ying An, Shao Hong Peng, Yuming Wei, Qianwen Wang, Knud J. Jensen, Zhong Zuo, Ho Yin Edwin Chan & Jacky Chi Ki Ngo. (2017) A brain-targeting lipidated peptide for neutralizing RNA-mediated toxicity in Polyglutamine Diseases. Scientific Reports 7:1.
Crossref
Ebtsam M. Abdou, Soha M. Kandil & Hala M.F. El Miniawy. (2017) Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion. International Journal of Pharmaceutics 529:1-2, pages 667-677.
Crossref
James C. League-Pascual, Cynthia M. Lester-McCully, Shaefali Shandilya, Lukas Ronner, Louis Rodgers, Rafael Cruz, Cody J. Peer, William D. Figg & Katherine E. Warren. (2017) Plasma and cerebrospinal fluid pharmacokinetics of select chemotherapeutic agents following intranasal delivery in a non-human primate model. Journal of Neuro-Oncology 132:3, pages 401-407.
Crossref
Weiping Lin, Xi Zheng, Huaqian Wang, Lin Yu, Xiaofen Zhou, Yunxiao Sun, Suqing Zhao, Zhiyun Du & Kun Zhang. (2017) Purification and characterization of a novel cell-penetrating carrier similar to cholera toxin chimeric protein. Protein Expression and Purification 129, pages 128-134.
Crossref
Reema Narayan, Mohan Singh, OmPrakash Ranjan, Yogendra Nayak, Sanjay Garg, Gopal V. Shavi & Usha Y. Nayak. (2016) Development of risperidone liposomes for brain targeting through intranasal route. Life Sciences 163, pages 38-45.
Crossref
Thomas Chen, Clovis Da Fonseca & Axel Schönthal. (2016) Perillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain Metastases. International Journal of Molecular Sciences 17:9, pages 1463.
Crossref
Brijesh Shah, Dignesh Khunt, Manju Misra & Harish Padh. (2016) “Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ”. International Journal of Biological Macromolecules 89, pages 206-218.
Crossref
Brijesh Shah, Dignesh Khunt, Manju Misra & Harish Padh. (2016) Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: Formulation, physicochemical and pharmacokinetic consideration. European Journal of Pharmaceutical Sciences 91, pages 196-207.
Crossref

Displaying 200 of 215 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.